MMP13 and osteoarthritis: In osteoarthritis (OA), SHED can reduce inflammation, increase the expression of collagen type 2 (COL 2), and decrease the expression of matrix metalloproteinase-13 (MMP-13) and nuclear factor-kB (NF-kB) and thus have the potential to be a treatment of OA [174].